Clinical Trial

Prevention and Treatment of Frostbite Infection With Antimicrobial Pharmacokinetic Analysis

Study acronym: Frostbite
Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated May 13, 2024 (before its estimated May 2026 completion). Its status may not reflect the trial's current state.
Summary
This study will compare the effectiveness of two different treatments for preventing infection from frostbite injuries. These two treatments are A) aloe vera and B) long-acting silver wound dressings. The investigators will also study the safety and effectiveness of Dalbavancin, an FDA approved antibiotic used for treating people who develop frostbite wound infections, as well as evaluate how frostbite damage to individuals' bodies may affect how fast their kidney clear drugs from their systems.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-02-15.
Status change: Not Yet Recruiting → Recruiting 2024-05-10
Trial Details
NCT Number NCT06266494
Lead Sponsor University of Colorado, Denver
Collaborators: Congressionally Directed Medical Research Programs
Conditions Frostbite
Enrollment 100 participants
Start Date 2024-03-01
Primary Completion 2026-05 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2024-05-13